Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 3)

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 3)

Central Nervous System Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 3)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Hepatic Insufficiency (Phase 1)

Hodgkin Disease (Phase 3)

Immunoblastic Lymphadenopathy (Phase 2)

Infections (Phase 2)

Kidney Neoplasms (Phase 2)

Leiomyomatosis (Phase 2)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Liver Failure (Phase 1)

Lung Neoplasms (Phase 3)

Lupus Nephritis (Phase 2)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Lymphoma, Mantle-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Cutaneous (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Nasopharyngeal Carcinoma (Phase 3)

Nasopharyngeal Neoplasms (Phase 3)

Neoplasms (Phase 3)

Nephritis (Phase 2)

Nervous System Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 3)

Prostatic Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 3)

Stomach Neoplasms (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Waldenstrom Macroglobulinemia (Phase 3)